Skip to main content
. 2012 May 24;42(5):319–328. doi: 10.4070/kcj.2012.42.5.319

Table 5.

Prognostic value of the rates of ApoB reduction for 12-month MACE

graphic file with name kcj-42-319-i005.jpg

*Reference group, Adjusted for age and gender, Adjusted for age, gender, creatinine, total cholesterol, triglyceride, Killip class, history of hyperlipidemia, clinical presentation with ST-elevation MI and ACC/AHA lesion type C. ACC/AHA: American College of Cardiology/American Heart Association, ApoB: apolipoprotein B, MI: myocardial infarction, MACE: major adverse cardiac events